Business Description
Kaleido Biosciences Inc
NAICS : 325412
SIC : 2836
ISIN : US4833471000
Description
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 99.21 | |||||
| 14-Day RSI | 95.43 | |||||
| 12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -7085.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 0.19 | |||||
| EV-to-EBITDA | 0.2 | |||||
| EV-to-Revenue | -15.2 | |||||
| Earnings Yield (Greenblatt) % | 526.32 | |||||
| FCF Yield % | -1955575 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KLDO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kaleido Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.104 | ||
| EPS (TTM) ($) | -2.16 | ||
| Beta | 72.62 | ||
| Volatility % | 1244.53 | ||
| 14-Day RSI | 95.43 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range ($) | 0.00001 - 0.03 | ||
| Shares Outstanding (Mil) | 42.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kaleido Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kaleido Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kaleido Biosciences Inc Frequently Asked Questions
What is Kaleido Biosciences Inc(KLDO)'s stock price today?
The current price of KLDO is $0.00. The 52 week high of KLDO is $0.03 and 52 week low is $0.00.
When is next earnings date of Kaleido Biosciences Inc(KLDO)?
The next earnings date of Kaleido Biosciences Inc(KLDO) is 2024-06-28 Est..
Does Kaleido Biosciences Inc(KLDO) pay dividends? If so, how much?
Kaleido Biosciences Inc(KLDO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers